5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort

British Journal of Nutrition

Volumn 84, Issue 6, 2000, Pages 891-896

  Chango, A ^a   De Potier Courcy, G ^b   Boisson, F ^a,b,c   Guilland, J C ^c   Barbe F ^a   Perrin, M O ^a   Christides J P ^b   Rabhi, K ^b   Pfister, M ^a   Galan, P ^b   Hercberg, S ^a   Nicolas, J P ^a  

^a INSERM   (France)

^b Bioinformatique et Chimie Moléculaire   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIOXIDANT; FOLIC ACID; HOMOCYSTEINE; MINERAL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; ERYTHROCYTE LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; FRANCE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; NORMAL HUMAN; PROTEIN POLYMORPHISM; SEX DIFFERENCE; VITAMIN SUPPLEMENTATION;

EID: 0034489473     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0007114500002518     Document Type: Article

References (31)

1. A quantitative assessment of plasma homocysteine as a risk factor for cardiovascular disease. Probable benefits of increasing folic acid intakes
2. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
3. Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
4. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: A randomized trial
5. Does the prevalent mutation 677C → T in the methylenetetrahydrofolate reductase gene account for hyperhomocysteine related to cardiovascular disease?
6. The effect of 677C → T and 1298A → C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects
7. Correlation of a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene with plasma homocysteine in patients with premature coronary artery disease
8. Teneur en acide folique des aliments. 2-Optimisation du dosage microbiologique des folates dans les aliments
9. Variability and determinants of total homocysteine concentrations in plasma in an elderly population
10. Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers
11. Methylenetetrahydrofolate reductase thermolabile variant and human longevity
12. A candidate genetic risk factor for vascular disease: A common mutation MTHFR
13. The common 'thermolabile' variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia
14. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in general population: The SU.VI.MAX study-design, methods, and participant characteristics
15. Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency
16. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
17. Vitamin B6 deficiency vs folate deficiency: Comparison of responses to methionine loading in rats
18. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations
19. Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: Differences between the radioassay and microbiological assays
20. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study
21. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland homocysteine study
22. The French paradox unmasked: The role of folate
23. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase
24. Inherited disorders of folate transport and metabolism
25. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation
26. Mild hyperhomocysteinemia and arterial occlusive disease
27. Analytical recovery of protein-bound pyridoxal-5′-phosphate in plasma analysis
28. Vitamin requirements for the treatment of hyperhomocysteinemia in humans
29. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?
30. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
31. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: A study in 52 healthy subjects